Suppr超能文献

桥本甲状腺炎、格雷夫斯病和甲状腺乳头状癌中浸润的γ/δ T细胞受体阳性淋巴细胞

Infiltrating gamma/delta T-cell receptor-positive lymphocytes in Hashimoto's thyroiditis, Graves' disease and papillary thyroid cancer.

作者信息

Paolieri F, Pronzato C, Battifora M, Fiorino N, Canonica G W, Bagnasco M

机构信息

Servizio di Allergologia e Immunologia Clinica Centro di Immunoendocrinologia DI.M.I.-Università di Genova, Italy.

出版信息

J Endocrinol Invest. 1995 Apr;18(4):295-8. doi: 10.1007/BF03347816.

Abstract

In the present study we have evaluated the expression of different molecular forms of the antigen receptor (TcR) on lymphocytes derived from thyroid tissue of patients with Graves' disease, Hashimoto thyroiditis and papillary cancer both in situ by APAAP technique and on isolated lymphocytes by indirect immunofluorescence. A panel of monoclonal antibodies (mAbs) recognizing alpha/beta and gamma/delta TcR-positive subsets was used. The results showed that the large majority of T-cells in thyroid infiltrates were alpha/beta TcR+, gamma/delta TcR+ ones being very rare or nearly absent, whatever the disease (autoimmune or neoplastic). No difference between gamma/delta TcR+ T-cell subsets (V delta 1+ or V delta 2+) was observed. Thus, neither in autoimmune thyroid diseases nor in papillary cancer gamma/delta TcR+ cells are likely to be a major effector-T cell population.

摘要

在本研究中,我们通过APAAP技术原位评估了Graves病、桥本甲状腺炎和乳头状癌患者甲状腺组织来源淋巴细胞上抗原受体(TcR)不同分子形式的表达,并通过间接免疫荧光法评估了分离淋巴细胞上的表达。使用了一组识别α/β和γ/δ TcR阳性亚群的单克隆抗体(mAb)。结果显示,无论疾病类型(自身免疫性或肿瘤性)如何,甲状腺浸润中的绝大多数T细胞为α/β TcR阳性,γ/δ TcR阳性的细胞非常罕见或几乎不存在。未观察到γ/δ TcR阳性T细胞亚群(Vδ1+或Vδ2+)之间的差异。因此,在自身免疫性甲状腺疾病和乳头状癌中,γ/δ TcR阳性细胞都不太可能是主要的效应T细胞群体。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验